- The Data: What’s Really Happening with Teen Depression
- When Medication Makes Sense (And When It Doesn’t)
- The Evidence: What Works for Adolescent Depression
- Understanding the Black Box Warning
- The Therapy-First Approach
- Why Combined Treatment Often Works Best
- Having the Conversation with Your Teen
- What to Expect If You Start Medication
- Frequently Asked Questions
⚡ Key Takeaways
- Antidepressant use in teens increased 66.3% from 2016 to 2022, with rates accelerating 63.5% faster after March 2020. Most of this increase has been among teenage girls
- Only two medications are FDA-approved for teen depression: fluoxetine (Prozac) for ages 8 and up, and escitalopram (Lexapro) for ages 12 and up
- Combined treatment with medication and therapy works better than either alone. The landmark TADS study found 71% response rates with combination treatment versus 61% for medication alone and 43% for therapy alone
- The black box warning about suicidal thoughts is real but often misunderstood. About 4% of teens on antidepressants experience increased suicidal thinking compared to 2% on placebo, but no completed suicides occurred in the clinical trials
- For mild depression, therapy should be tried first. Medication becomes the primary recommendation when depression is moderate to severe or when therapy alone hasn’t helped after 12 weeks
I know what you’re thinking. How did we get here? Your kid was fine last year, and now they barely get out of bed. They’ve stopped seeing friends. Their grades are dropping. You’ve tried everything you can think of, and nothing seems to help.
When a psychiatrist or pediatrician brings up antidepressants, it can feel like both a relief and a whole new source of anxiety. Maybe medication will help. But what about the side effects? What about those warnings you’ve heard? What if it makes things worse?
Let me be clear about something. This decision doesn’t have to be scary if you have good information. The goal of this guide is to give you the facts, the research, and the context you need to make an informed choice with your teenager. Not for your teenager, with them. This is a decision you should make together.
The Data: What’s Really Happening with Teen Depression
Before we talk about medication, let’s look at what’s happening with adolescent mental health. These numbers matter because they provide context for why more teenagers are taking antidepressants.
Teen Depression Has Increased Dramatically
According to the CDC, 19% of teens aged 12-19 reported symptoms consistent with depression from 2021 to 2023. That’s nearly 1 in 5 teenagers. For certain groups, the numbers are even more concerning. About 53% of teenage girls and 65% of LGBTQ+ teens report prolonged feelings of sadness or hopelessness.
These aren’t just bad moods or typical teenage angst. Clinical depression is characterized by persistent sadness, loss of interest in activities, changes in sleep and appetite, difficulty concentrating, feelings of worthlessness, and sometimes thoughts of death or suicide. It interferes with school, relationships, and daily functioning.
Antidepressant Prescriptions Have Surged
A 2024 study published in Pediatrics analyzed more than 221 million antidepressant prescriptions for adolescents and young adults between 2016 and 2022. Here’s what they found.
| Time Period | Monthly Dispensing Rate (per 100,000) | Change |
|---|---|---|
| January 2016 | 2,576 | Baseline |
| December 2022 | 4,285 | +66.3% overall increase |
| Pre-COVID (2016-Feb 2020) | +17.0 per month | Steady increase |
| Post-COVID (Mar 2020-2022) | +27.8 per month | 63.5% faster rate of increase |
The increase was not evenly distributed. Among teenage girls aged 12-17, antidepressant dispensing increased 129.6% faster after March 2020 compared to before. For young women aged 18-25, the increase was 56.5% faster. In contrast, the monthly rate actually decreased for teenage boys aged 12-17 during the pandemic.
Why the Increase?
Several factors are driving these numbers. The pandemic disrupted social connections, educational routines, and family dynamics. Social media use has been linked to increased anxiety and depression in adolescents. Academic pressure has intensified. Access to mental health services has expanded in some areas, meaning more teens are getting diagnosed and treated.
But here’s what matters most: these prescriptions aren’t being written frivolously. Each one represents a teenager struggling enough that a medical professional believed medication could help.
“My 15-year-old daughter has been really depressed for about 6 months now. Her therapist is suggesting we talk to a psychiatrist about medication. I’m terrified. I’ve heard so many horror stories about antidepressants making teens suicidal. How do you even know if the medication is the right call versus just more therapy? I don’t want to drug my kid if there’s another way.”
I understand your fear completely. The fact that her therapist is recommending a psychiatric consultation suggests your daughter’s depression is moderate to severe, or that therapy alone hasn’t provided enough relief after a reasonable trial period. Here’s what I tell parents: we would never recommend medication if we didn’t believe the benefit outweighed the risk. For moderate to severe depression, the research is clear that SSRIs like fluoxetine are effective and generally safe. The suicidal thinking risk is real but small (about 2% increased risk), and it’s closely monitored. The bigger risk is often untreated depression itself. A thorough evaluation will help determine whether medication makes sense for your daughter’s specific situation.
When Medication Makes Sense (And When It Doesn’t)
Not every teenager with depression needs medication. Let me be very clear about that. For some teens, therapy alone is sufficient and appropriate. For others, medication becomes an important part of treatment. Understanding when each approach makes sense is crucial.
Mild Depression: Start with Therapy
If your teenager has mild depression, meaning they’re struggling but still able to function in most areas of their life, the first-line recommendation is psychotherapy. Specifically, cognitive behavioral therapy (CBT) or interpersonal therapy (IPT) have strong evidence for treating mild adolescent depression.
Mild depression might look like this: your teen seems sad or irritable more days than not, has lost interest in some activities, is sleeping more than usual, and their grades have dropped a bit. But they’re still going to school most days, maintaining some friendships, and able to do basic self-care. This is someone who should try therapy first.
Moderate to Severe Depression: Consider Medication Earlier
When depression is moderate to severe, the clinical picture changes. Now we’re talking about significant functional impairment. Your teen might be missing school frequently, has withdrawn from all social activities, shows dramatic changes in sleep or appetite, expresses feelings of worthlessness or hopelessness, or has thoughts of death or self-harm.
For moderate to severe depression, research supports starting with either medication plus therapy (combined treatment) or medication alone, followed by adding therapy. This isn’t because therapy doesn’t work. It’s because severely depressed teenagers often lack the energy, motivation, and cognitive capacity to fully engage in therapy. Medication can help them reach a baseline where they’re able to participate meaningfully in the therapeutic work.
When Therapy Alone Hasn’t Worked
If your teenager has been in therapy for 12 weeks or more without significant improvement, medication should be seriously considered. This doesn’t mean therapy has failed. It means your teen’s depression may have a stronger biological component that requires pharmacological intervention to address.
Some teenagers have what’s called treatment-resistant depression, where multiple interventions are needed to achieve remission. In these cases, medication becomes part of a comprehensive treatment plan, not a replacement for therapy.
Special Circumstances
There are situations where medication becomes the clear choice even if you might otherwise wait. If your teenager is actively suicidal and requires hospitalization, medication is typically started immediately. If they have a family history of depression that responds well to medication, this increases the likelihood they’ll respond similarly. If their depression includes psychotic features (hallucinations or delusions), medication is essential and therapy alone is insufficient.
The Evidence: What Works for Adolescent Depression
Let’s talk about what the research actually shows. This is where evidence meets real-world application.
FDA-Approved Medications for Teen Depression
Only two antidepressants have FDA approval specifically for treating depression in adolescents. Fluoxetine (Prozac) is approved for ages 8 and up. Escitalopram (Lexapro) is approved for ages 12 and up. Both are selective serotonin reuptake inhibitors, or SSRIs.
This doesn’t mean other SSRIs don’t work. Sertraline (Zoloft), citalopram (Celexa), and other SSRIs are frequently prescribed off-label and have been studied in adolescents. But fluoxetine has the strongest evidence base and is typically the first choice.
How SSRIs Work
SSRIs work by blocking the reabsorption (reuptake) of serotonin in the brain. This leaves more serotonin available to facilitate communication between neurons. Serotonin is involved in mood regulation, and while the old “chemical imbalance” theory has been questioned, there’s no doubt that SSRIs are effective for many adolescents with depression.
These medications don’t provide immediate relief. They typically take 4-6 weeks to show full effects. Some teenagers notice improvements in sleep, appetite, or energy within the first 2 weeks, but mood improvement usually takes longer.
“My son’s psychiatrist wants to start him on Prozac. But I read online that only Prozac and Lexapro are FDA approved for teens. Does that mean all the other antidepressants are dangerous? Should I push for one of the approved ones? Also, how long until we know if it’s working?”
The FDA approval status doesn’t mean other medications are dangerous. It means fluoxetine and escitalopram have been studied extensively enough in adolescents to receive formal approval. Other SSRIs like sertraline have also been well-researched in teens and are considered safe and effective. They’re prescribed “off-label,” which is very common in pediatric medicine. Prozac is an excellent first choice and has the most robust evidence. As for timing, you’ll likely see some early changes in sleep or appetite within 2 weeks, but give it a full 4-6 weeks to assess whether it’s truly helping your son’s depression. If there’s no improvement by 6 weeks, we’d consider adjusting the dose or trying a different medication.
What About Other Medications?
Some antidepressants studied in teens have not shown efficacy in clinical trials. Paroxetine, for example, failed to separate from placebo and showed higher rates of suicidal thinking. Venlafaxine (an SNRI) also didn’t show efficacy for depression in adolescents, though it’s sometimes used for anxiety disorders.
This is why sticking with medications that have a proven track record in adolescents matters. Fluoxetine, escitalopram, and to a lesser extent sertraline, have the evidence to support their use.
Understanding the Black Box Warning
Let’s address the elephant in the room. Every antidepressant carries a black box warning, the FDA’s strongest warning short of an outright ban. The warning states that antidepressants may increase the risk of suicidal thoughts and behaviors in children, adolescents, and young adults up to age 25.
This warning terrifies parents. It should be taken seriously. But it’s also widely misunderstood.
What the Data Actually Shows
The black box warning came from a 2004 FDA analysis of nearly 400 clinical trials involving more than 4,400 children and adolescents. The analysis found that 4% of young people taking antidepressants experienced suicidal thoughts or behavior, compared to 2% taking placebo. That’s a 2-fold increase, or an absolute increase of 2%.
Here’s the critical point: there were no completed suicides in any of these trials. The increased risk was for suicidal ideation (thoughts) and non-fatal suicide attempts, not death by suicide.
The Unintended Consequences
The black box warning had a chilling effect. Antidepressant prescriptions for adolescents dropped by more than 30% after 2004. Prescriptions for adults also decreased, even though there was no data suggesting increased suicidality in older age groups.
What happened to suicide rates during this period? They went up. Suicide rates among teens and young adults increased dramatically in the decade following the warning, reversing a previous downward trend. This suggests that undertreating depression may pose a greater risk than the medications themselves.
How to Manage the Risk
The key to managing suicidality risk is close monitoring, especially in the first few weeks of treatment. Here’s what responsible prescribing looks like.
Weekly check-ins for the first month. Either in person or by phone, your teen should be in contact with their prescriber weekly for the first 4 weeks. This allows early detection of any concerning changes in mood or behavior.
Parents should watch for warning signs. Increased agitation, new or worsening anxiety, panic attacks, insomnia, irritability, hostility, impulsivity, severe restlessness, or rapid speech can all be signs of activation syndrome, which sometimes precedes suicidal thinking.
Open communication about suicidal thoughts. Your teenager needs to know they can tell you if they’re having thoughts of self-harm. This won’t make them more likely to act on those thoughts. It creates a safety net.
Direct conversation with your teen. Before starting medication, have an honest discussion about the black box warning. Explain that suicidal thoughts can sometimes increase in the first few weeks, and if that happens, they need to tell you immediately so you can contact their doctor. Frame it as a known, manageable side effect, not a catastrophe.
The Therapy-First Approach
Psychotherapy is not just a nice addition to medication. For many teenagers, it’s the primary treatment. Let’s talk about what makes therapy effective for adolescent depression.
Cognitive Behavioral Therapy (CBT)
CBT is the most extensively studied psychotherapy for teen depression. It works by helping adolescents identify and change negative thought patterns and behaviors that contribute to depression.
A CBT therapist might teach your teenager to recognize cognitive distortions, like all-or-nothing thinking (“I failed one test, so I’m a complete failure”) or catastrophizing (“If I don’t get into a good college, my life will be ruined”). They learn to challenge these thoughts and replace them with more balanced, realistic perspectives.
CBT also focuses on behavioral activation. When people are depressed, they tend to withdraw from activities that previously brought them joy. This creates a vicious cycle. The less they do, the worse they feel. CBT helps break this cycle by gradually reintroducing pleasurable and meaningful activities.
Interpersonal Therapy (IPT)
IPT focuses on the connection between mood and interpersonal relationships. It’s based on the idea that depression often arises from or is maintained by problems in relationships, such as grief, role transitions, role disputes, or interpersonal deficits.
For adolescents, who are navigating complex social dynamics and identity formation, IPT can be particularly relevant. A teenager struggling with depression after a breakup, conflict with parents, or difficulty fitting in at school might benefit significantly from IPT.
How Long Should You Try Therapy Alone?
The standard recommendation is 12 weeks of therapy before concluding that therapy alone is insufficient. Some teenagers respond more quickly, showing improvement within 6-8 weeks. Others need the full 12 weeks to benefit.
If your teenager has shown no improvement after 12 weeks of quality therapy (meaning they’re attending regularly and engaging with the process), that’s when medication should be seriously considered. Don’t let anyone tell you that continuing ineffective therapy for months or years is the “natural” approach. Untreated depression has consequences.
Why Combined Treatment Often Works Best
The landmark study on this question is the Treatment for Adolescents with Depression Study, known as TADS. It’s one of the largest and most rigorous trials ever conducted on adolescent depression treatment.
The TADS Study Design
TADS randomly assigned 439 adolescents aged 12-17 with major depressive disorder to one of four groups: fluoxetine alone, CBT alone, combined treatment (fluoxetine plus CBT), or placebo. Participants were followed for 36 weeks.
The results were striking and have shaped clinical practice ever since.
The 12-Week Results
| Treatment Group | Response Rate at 12 Weeks | Key Findings |
|---|---|---|
| Combined (Fluoxetine + CBT) | 71% | Highest response rate, best safety profile |
| Fluoxetine alone | 61% | Superior to CBT alone and placebo |
| CBT alone | 43% | Not significantly better than placebo |
| Placebo | 35% | Baseline comparison |
Combined treatment was statistically superior to both fluoxetine alone and CBT alone. Fluoxetine alone was superior to CBT alone. And here’s what surprised many people: CBT alone was not significantly more effective than placebo at 12 weeks.
Does this mean CBT doesn’t work? Not exactly. CBT “caught up” with fluoxetine by week 18, with both achieving similar response rates. By week 36, all three active treatments converged around an 80% response rate. But combined treatment reached maximum benefit several months earlier than either monotherapy.
The Safety Findings
Perhaps more importantly, the TADS study showed that combined treatment had the best safety profile. Suicidal events were more common in adolescents receiving fluoxetine alone (14.7%) compared to combined treatment (8.4%) or CBT alone (6.3%).
This suggests that adding CBT to medication enhances the safety of the medication. The therapy component provides teens with coping skills that help manage suicidal thoughts if they arise.
Why Combined Treatment Works Better
Think of it this way. Depression has biological, psychological, and social components. Medication addresses the biological piece, helping to restore normal neurotransmitter function and neural connectivity. Therapy addresses the psychological and social pieces, teaching skills for managing thoughts, emotions, and relationships.
When you treat both simultaneously, you’re attacking the problem from multiple angles. The medication gives your teenager enough energy and emotional stability to engage meaningfully in therapy. The therapy gives them tools to maintain their improvement and prevent relapse once the medication is eventually discontinued.
“Our psychiatrist recommended both Prozac and weekly therapy for our 14-year-old daughter. My insurance covers the medication, but therapy is $200 a session out of pocket. We can’t really afford that. Is it okay to just do the medication? The psychiatrist made it sound like we really need to do both, but I don’t know how we can swing it financially.”
This is a very real challenge many families face. While combined treatment is ideal, medication alone is still effective and certainly better than no treatment at all. The TADS study showed a 61% response rate with fluoxetine alone, which is substantial. That said, I’d encourage you to explore lower-cost therapy options. Many therapists offer sliding scale fees. Community mental health centers often provide affordable services. Some graduate training programs offer therapy provided by supervised trainees at reduced rates. Group therapy for teens with depression can be effective and is typically less expensive than individual therapy. If you absolutely can’t access therapy right now, medication alone is a reasonable choice, with close monitoring by the prescriber.
Having the Conversation with Your Teen
This isn’t a decision you should make for your teenager. It’s a decision you should make with them. Even though you’re the parent and legally authorized to consent to treatment, your teen’s buy-in is crucial for success.
Timing the Conversation
Don’t spring this on them in the psychiatrist’s office. Before the appointment, sit down with your teenager in a comfortable, private setting. Choose a time when neither of you is rushed or stressed.
What to Say
Start by acknowledging what they’re going through. “I know you’ve been struggling with depression. I can see how hard things have been for you, and I want you to know I’m here to support you.”
Explain that you have an appointment with a psychiatrist who specializes in helping teenagers with depression. Frame it as getting more information and exploring options, not as a done deal.
“The psychiatrist will evaluate your symptoms and talk with us about different treatment options. One option might be medication. I want to hear what the doctor says, and I want to hear what you think too. This is your health, and your opinion matters.”
Address Their Concerns Directly
Teenagers often have specific worries about antidepressants. They might worry about side effects, about feeling like a different person, about what their friends will think, or about being on medication long-term.
Listen to their concerns without dismissing them. “I hear you saying you’re worried about side effects. That’s a really valid concern. Let’s make sure we ask the doctor about that. I want you to understand what the potential side effects are so you can make an informed decision.”
Emphasize Their Agency
While you ultimately have the legal authority to make treatment decisions, emphasizing your teenager’s input increases their engagement and compliance. “If we decide together that medication makes sense, I need you to be honest with me about how you’re feeling on it. If something doesn’t feel right, I need you to tell me. And if you decide after trying it that it’s not working for you, we can talk to the doctor about adjusting or stopping it.”
What Not to Say
Avoid minimizing their experience. Don’t say things like “Everyone feels sad sometimes” or “You just need to try harder to be positive.” Depression is a medical condition, not a character flaw or a choice.
Don’t present medication as a magic fix. “This isn’t going to instantly make everything better. It takes time, and it works best when combined with therapy and lifestyle changes. Think of it as one tool in a toolbox.”
Don’t make promises you can’t keep. Don’t say “You’ll definitely feel better in a few weeks” or “There won’t be any side effects.” Be honest about the uncertainties while remaining hopeful.
What to Expect If You Start Medication
Let’s walk through what the first few weeks and months typically look like when a teenager starts an SSRI for depression.
The First Week
Your teenager will probably start on a low dose. For fluoxetine, this is typically 10mg daily. The medication is usually taken in the morning because it can sometimes cause insomnia if taken at night.
Common early side effects include mild nausea, stomach upset, headache, or increased anxiety. These symptoms usually subside within the first week or two as the body adjusts. Taking the medication with food can help with nausea.
Some teenagers experience activation, meaning they feel more energized or even a bit jittery. This is usually mild and temporary, but if it’s severe or includes new suicidal thoughts, contact the prescriber immediately.
Weeks 2-4
Early changes often appear in sleep, appetite, and energy before mood improves. Your teen might start sleeping more regularly, eating better, or having slightly more energy. These are good signs that the medication is working, even if their mood hasn’t lifted yet.
Weekly check-ins with the prescriber are standard during this period. These might be brief phone calls or virtual visits, just to make sure no concerning symptoms have emerged.
Weeks 4-8
This is when you typically start seeing mood improvements. Your teenager might seem less irritable, more engaged, or show renewed interest in activities they’d abandoned. The change is often gradual rather than sudden.
If there’s been no improvement by week 6, the doctor might increase the dose. For fluoxetine, the usual therapeutic range is 20-40mg daily. Dose adjustments should be made gradually, with adequate time (usually 4-6 weeks) to assess the effect before changing again.
Months 3-9
Once your teenager has responded well to medication, the goal is to maintain that response and prevent relapse. They should continue taking the medication for at least 9-12 months after achieving remission. Stopping too early significantly increases the risk of depression returning.
Therapy should continue during this period. The skills learned in therapy provide protection against relapse even after medication is eventually discontinued.
Side Effects to Monitor
Most side effects are mild and temporary. The most common include gastrointestinal symptoms (nausea, diarrhea), headache, insomnia or drowsiness, and mild activation or restlessness.
Some teenagers experience decreased appetite and weight loss, though this usually stabilizes over time. Sexual side effects (decreased libido, difficulty with orgasm) can occur in adolescents, though they’re often reluctant to report these. Creating a safe space for your teen to discuss any side effects is important.
Serious side effects are rare but include serotonin syndrome (symptoms include confusion, agitation, rapid heart rate, high blood pressure, dilated pupils, and in severe cases, seizures) and significant bleeding risk when combined with NSAIDs or blood thinners.
When and How to Stop
After 9-12 months of stability, you and the doctor can discuss discontinuing medication. This should be done gradually by tapering the dose, not by stopping abruptly. Sudden discontinuation can cause withdrawal symptoms.
The risk of relapse is highest in the first few months after stopping. Some teenagers will need to go back on medication if depression returns. This isn’t a failure. It just means they need longer-term treatment, which is perfectly acceptable.
Frequently Asked Questions
Ready to Discuss Your Teen’s Treatment Options?
Dr. Erkut provides comprehensive psychiatric evaluations for adolescents, offering evidence-based recommendations and close monitoring throughout treatment. She works collaboratively with families to make informed decisions about medication, therapy, and combined approaches.
SCHEDULE AN ADOLESCENT EVALUATION
Sources & References
- Chua KP, Volerman A, Zhang J, Hua J, Conti RM. (2024). Antidepressant Dispensing to US Adolescents and Young Adults: 2016-2022. Pediatrics, 153(3):e2023064245.
- March J, Silva S, Petrycki S, et al. (2004). Fluoxetine, Cognitive-Behavioral Therapy, and Their Combination for Adolescents With Depression: Treatment for Adolescents With Depression Study (TADS) Randomized Controlled Trial. JAMA, 292(7):807-820.
- March JS, Silva S, Petrycki S, et al. (2007). The Treatment for Adolescents With Depression Study (TADS): Long-term Effectiveness and Safety Outcomes. Archives of General Psychiatry, 64(10):1132-1143.
- Bridge JA, Iyengar S, Salary CB, et al. (2007). Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA, 297(15):1683-1696.
- American Academy of Child and Adolescent Psychiatry. Practice Parameter for the Assessment and Treatment of Children and Adolescents with Depressive Disorders. Journal of the American Academy of Child & Adolescent Psychiatry.
- Cipriani A, Zhou X, Del Giovane C, et al. (2016). Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. The Lancet, 388(10047):881-890.
- Brent D, Emslie G, Clarke G, et al. (2008). Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA, 299(8):901-913.
- FDA. (2004). Suicidality in Children and Adolescents Being Treated With Antidepressant Medications. FDA Public Health Advisory.
This content is for informational purposes only and does not constitute medical advice. Treatment decisions for adolescent depression must be made with a qualified healthcare provider who can evaluate your teenager’s specific circumstances, including severity of symptoms, prior treatment history, and individual risk factors. Dr. Erkut provides personalized psychiatric evaluations and works closely with families to develop appropriate treatment plans.